Correspondence on "cost or price of sequencing? implications for economic evaluations in genomic medicine" by Grosse and Gudgeon

Genet Med. 2022 Jan;24(1):251-252. doi: 10.1016/j.gim.2021.08.006. Epub 2021 Nov 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Evidence-Based Medicine*
  • Genomic Medicine*
  • Humans